Resonance Health
Resonance Health is a MedTech company specializing in non-invasive medical imaging analysis, particularly in iron overload and liver disease management. Their portfolio includes post-MRI analysis tools like FerriScan and HepaFatScan, providing quantitative calculations and evaluations essential for disease management and clinical trials.
Short position
Resonance Health (ASX:RHT) has 0.02% of its shares on issue reported as short positions as of 25 Sept 2026, or about 71,783 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.23% in February 2019. RHT is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Resonance Health (RHT) company profile
Profile, insiders and operations
Company
AI-generated research profile of Resonance Health
RHT intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links